The final report, presented to New York Governor Kathy Hochul, outlines a path to translate investments in the state's biotech ecosystem into real-world outcomes. -- Executives from The Michael J. Fox ...
Adaptive Biotechnologies said on Monday it has signed two non-exclusive deals with Pfizer to support research in rheumatoid ...
Pfizer logo is reflected in a drop on a syringe needle in this illustration photo (Reuters) -Pfizer Inc plans to tap the gene-based technology behind its successful COVID-19 shot to develop new ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Jessica was a writer on the Wellness team, with a focus on health technology, eye care, nutrition and finding new approaches to chronic health problems. Expertise Public health, new wellness ...
On the heels of its rapid development of a COVID-19 vaccine, Pfizer will attempt to use the same gene-based technology to advance other vaccines against a host of diseases, CEO Albert Bourla, Ph.D., ...
Pharmaceutical Technology on MSN
Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures
Alongside its cost-cutting strategy, Pfizer has been investing into its cardiometabolic pipeline in a bid to enter the ...
Moderna said Friday that it is suing Pfizer and BioNTech, alleging that the two companies copied Moderna's technology to make their Covid vaccine Comirnaty. "We believe that Pfizer and BioNTech ...
With its COVID-19 vaccine being injected into millions of arms, Pfizer is looking ahead to what comes next. The pharmaceutical company plans to begin testing its mRNA technology to create new vaccines ...
Moderna is suing fellow vaccine developers Pfizer and its German partner BioNTech, accusing it of infringing on patents related to mRNA technology used in their COVID-19 vaccine, the company announced ...
Pharmaceutical Technology on MSN
Pfizer plans job cuts in Switzerland to reduce expenses
Pfizer is set to cut several jobs in Switzerland as part of a multi-year effort to lower expenses, as reported by Bloomberg.
Moderna is suing Pfizer and BioNTech, accusing its main competitors of copying its technology in order to make their own COVID-19 vaccine. Moderna said Friday that Pfizer and Germany-based BioNTech’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results